Darnytsia's breakthrough in carrying out drug&s release
In general, according to the previously announced information by the company, the manufacturer plans to release 25 more new drugs, some of them in cooperation with European pharmaceutical companies that have quite a high rating and are respected among the pharmaceutical industry.
The Darnytsia pharmaceutical company in the first three months of 2021, delivered to the market five drugs for treating cardiac, neurological, gastroenterological, and respiratory diseases, which are claimed to be the most spread and needed by the common population. This was reported by the company&s press service and previously noted by the Chairman of the Board of Directors, Dmytro Shymkiv, at one of the conferences he attended.
So, in March, the drug for the treatment of dementia Memtek was finally presented for official sale. It is produced in the European Union for Darnytsia, which ensures the quality of the introduced drug. Moreover, it is not the first time the company collaborates with European companies to develop new formulas of treatment of the most basic illnesses.
It is noted that the acceleration of the release became possible due to the transition to electronic pharmaceutical document management, digitalization of clinical research processes, and monitoring of drug use. Otherwise, such an important issue would be postponed for another prolonged period of time. «More than half of the launches occur in advance, which is 1 to 3 months for different products,» - This is what the official message says.
According to the presented plan, the company considers releasing 25 more new drugs, some of them in cooperation with European pharmaceutical companies, in order to strengthen the bonds between Ukraine and the European Union in the pharmacological industry.
Generally, during 2015-2019, Darnytsia released more than 50 pharmaceutical brands, having invested about UAH 1.1 billion in R&D. Nowadays, it has to rapidly increase the amount of completed projects and fulfill more than a half of amount in just one year, which is mostly caused by the current prosperity of pharmacy as an industry in the world.
Due to the coronavirus pandemic last year, Darnytsia changed production plans to provide the population with antiviral and antipyretic drugs in order to cover the need of them among the common customers. In particular, additional production of Immustat began, and an extra-large batch of Paracetamol was released. They were admitted to be the essential drugs to use when feeling like someone has caught a cold.
Published 22.04.2021 12:44
Source - Ereport.ru